Skip to main content

A local hemostatic agent for the management of postpartum hemorrhage due to placenta previa and placenta accreta: a cross-sectional study



To describe the use of a local hemostatic agent (LHA) for the management of postpartum hemorrhage (PPH) due to bleeding of the placental bed in patients taken to caesarean section at Fundación Santa Fe de Bogotá University Hospital.


A total of 41 pregnant women who had a caesarean section and developed PPH.


A cross-sectional study. Analysis of all cases of PPH during caesarean section presented from 2006 up to and including 2012 at Fundación Santa Fe de Bogotá University Hospital.

Main outcome measure

Emergency hysterectomy due to PPH.


The proportion of hysterectomies was 5 vs. 66 % for the group that received and did not receive management with a LHA respectively (PR 0.07, CI 95 % 0.01–0.51 p < 0.01). For the group managed without a LHA, 80 % of patients needed hemoderivatives transfusion vs. 20 % of patients in the group managed with a LHA (PR 0.24, CI 95 % 0.1–0.6 p < 0.01). A reduction in the mean days of hospitalization in addition to a descent in the proportion of patients admitted to the intensive care unit (ICU) was noticed when comparing the group that received a LHA versus the one that did not.


An inverse association between the use of a LHA in patients with PPH due to bleeding of the placental bed and the need to perform an emergency obstetric hysterectomy was observed. Additionally there was a significant reduction in the mean duration of hospital stay, use of hemoderivatives and admission to the ICU.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2



Postpartum hemorrhage


Local hemostatic agent


Prevalence ratio


Intensive care unit


  1. AbouZahr C (2003) Global burden of maternal death and disability. In: Rodeck C (ed) Reducing maternal death and disability in pregnancy. Oxford University Press, Oxford, pp 1–11

    Google Scholar 

  2. Oyelese Y, Ananth CV (2010) Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 53(1):147–156

    Article  PubMed  Google Scholar 

  3. Departamento Administrativo Nacional de Estadística (DANE) [Internet]. Defunciones No fetales 2009 [cited 2012 Jun] Available from: Español

  4. Wu S, Kocherginsky M, Hibbard JU (2005) Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 192:1458–1461

    Article  PubMed  Google Scholar 

  5. Clark SL, Koonings PP, Phelan JP (1985) Placenta previa/accreta and prior cesarean section. Obstet Gynecol 66:89–92

    PubMed  CAS  Google Scholar 

  6. Silver RM, Landon MB, Rouse DJ (2006) National Institute of child health and human development maternal-fetal medicine units network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 107:1226–1232

    Article  PubMed  Google Scholar 

  7. Baumann P, Schumacher H, Hüsing J, Luntz S, Knaebel HP (2009) A randomized, controlled, prospective trial to evaluate the haemostatic effect of lyostypt versus surgicel in arterial bypass anastomosis: “COBBANA” trial. Trials 29(10):91

    Article  Google Scholar 

  8. Barnard J, Millner R (2009) A review of topical hemostatic agents for use in cardiac surgery. Ann Thorac Surg 88(4):1377–1383

    Article  PubMed  Google Scholar 

  9. Renkens KL Jr, Payner TD, Leipzig TJ, Feuer H, Morone MA, Koers JM et al (2001) A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine (Phila Pa 1976) 26(15):50–1645

    Article  Google Scholar 

  10. Moriarty KT, Premila S, Bulmer PJ (2008) Use of FsloSeal haemostatic gel in massive obstetric haemorrhage: a case report. BJOG 115:793–795

    Article  PubMed  CAS  Google Scholar 

  11. Law LW, Chor CM, Leung TY (2010) Use of hemostatic gel in postpartum hemorrhage due to placenta previa. Obstet Gynecol 116(Suppl 2):528–530

    Article  PubMed  Google Scholar 

  12. Whiteside JL, Asif RB, Novello RJ (2010) Fibrin sealant for management of complicated obstetric lacerations. Obstet Gynecol 115:403–404

    Article  PubMed  Google Scholar 

  13. Fuglsang K, Petersen LK (2010) New local hemostatic treatment for postpartum hemorrhage caused by placenta previa at cesarean section. Acta Obstet Gynecol Scand 89(10):1346–1349

    Article  PubMed  Google Scholar 

  14. Mercier FJ, Van de Velde M (2008) Major obstetric hemorrhage. Anesthesiol Clin 26(1):53–66

    Article  PubMed  Google Scholar 

  15. Varatharajan L, Chandraharan E, Sutton J, Lowe V, Arulkumaran S (2011) Outcome of the management of massive postpartum hemorrhage using the algorithm “HEMOSTASIS”. Int J Gynaecol Obstet 113(2):152–154

    Article  PubMed  Google Scholar 

  16. Rossi AC, Lee RH, Chmait RH (2010) Emergency postpartum hysterectomy for uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol 115(3):637–644

    Article  PubMed  Google Scholar 

  17. Hossain N, Shah T, Khan N, Shah N, Khan NH (2011) Transfusion of blood and blood component therapy for postpartum haemorrhage at a tertiary referral center. J Pak Med Assoc 61(4):343–345

    PubMed  Google Scholar 

  18. Mariño CA, Vargas DC. Caracterización de la morbilidad materna extrema en el Instituto Materno Infantil––Hospital la Victoria [Internet]. Universidad Nacional de Colombia 2010 Español. Available from:

  19. Yoong W, Massiah N, Oluwu A (2006) Obstetric hysterectomy: changing trends over 20 years in a multiethnic high risk population. Arch Gynecol Obstet 274:37–40

    Article  PubMed  Google Scholar 

  20. Daskalakis G, Anastasakis E, Papantoniou N, Mesogitis S, Theodora M, Antsaklis A (2007) Emergency obstetric hysterectomy. Acta Obstet Gynecol Scand 86(2):223–227

    Article  PubMed  Google Scholar 

  21. Kastner ES (2002) Fifueroa R, Garry D. emergency peripartum hysterectomy: experience at a community teaching hospital. Obstet Gynecol 99:971–975

    Article  PubMed  Google Scholar 

  22. Zelop CM, Harlow BL, Frigoletto FD, Safon LE (1993) Emergency peripartum hysterectomy. Am J Obstet Gynecol 168:1443–1448

    Article  PubMed  CAS  Google Scholar 

  23. Petersen LK, Oxlund H, Uldbjerg N, Forman A (1991) In vitro analysis of muscular contractile ability and passive biomechanical properties of uterine cervical samples from nonpregnant women. Obstet Gynecol 77(5):772–776

    PubMed  CAS  Google Scholar 

  24. Richter F, Schnorr D, Deger S, Trk I, Roigas J, Wille A et al (2003) Improvement of hemostasis in open and laparoscopically performed partial nephrectomy using a gelatin matrix-thrombin tissue sealant (FloSeal). Urology 61:73–77

    Article  PubMed  Google Scholar 

  25. Lemmer R, Albrech M, Bauer G (2012) Use of FloSeal hemostatic matrix in a patient with severe postpartum hemorrhage. J Obstet Gynaecol Res 38(2):435–437

    Article  PubMed  Google Scholar 

  26. Ethicon, Inc.(2007).A compendium of scientific literature: Evidence supporting the efficacy and safety of the SURGICEL® Family of absorbable hemostats. Neuchatel, Switzerland. Retrieved March 5, 2013 from

Download references

Conflict of interest

The authors state explicitly that there are no conflicts of interest to be disclosed.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Cristian Hernández-Giraldo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Portilla, D., Hernández-Giraldo, C., Moreno, B. et al. A local hemostatic agent for the management of postpartum hemorrhage due to placenta previa and placenta accreta: a cross-sectional study. Arch Gynecol Obstet 288, 543–549 (2013).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Postpartum Hemorrhage
  • Cellulose, Oxidized
  • Hysterectomy
  • Placenta previa
  • Placenta accreta